PCM
BMY.RT

Parsons Capital Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Parsons Capital Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-81,825
Closed -$56K – 417
2020
Q4 		$56K Sell
81,825
-88,092
-52% -$188K ﹤0.01% 373
2020
Q3 		$382K Sell
169,917
-4,420
-3% -$12.6K 0.04% 269
2020
Q2 		$624K Buy
174,337
+26,735
+18% +$96.5K 0.07% 210
2020
Q1 		$561K Buy
147,602
+39,767
+37% +$131K 0.07% 207
2019
Q4 		$325K Buy
+107,835
New +$280K 0.03% 291

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Parsons Capital Management's BMY.RT Position: Q1 2021 in Review

Parsons Capital Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 81,825 shares — an estimated $56K sold.

Parsons Capital Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $624K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Parsons Capital Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Parsons Capital Management sold 81,825 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $56K.
  • Parsons Capital Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Parsons Capital Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $624K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Parsons Capital Management's 13F filing for Q1 2021, filed 28 Apr 2021.